Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy

Journal of the American College of Cardiology

Volumn 43, Issue 10, 2004, Pages 1908-1914

  Askari, Arman ^a   Unzek, Samuel ^a   Goldman, Corey K ^a   Ellis, Stephen G ^a   Thomas, James D ^a   DiCorleto, Paul E ^a   Topol, Eric J ^a   Penn, Marc S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

adenoviral Luciferase; adenoviral vascular endothelial growth factor 165; AdLuc; AdVEGF 165; LAD; left anterior descending coronary artery; left ventricle ventricular; LV; MI; myocardial infarction; skeletal myoblasts; SKMB

Indexed keywords

ADENOVIRUS VECTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIOMYOPATHY; CELL TRANSPLANTATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DENSITY; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; GENE TARGETING; GENETIC TRANSFECTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; MALE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ADENOVIRIDAE; ANIMALS; CARDIOMYOPATHY, DILATED; CORONARY VESSELS; GENE THERAPY; GENETIC VECTORS; GROWTH SUBSTANCES; ISCHEMIA; MALE; MODELS, ANIMAL; MYOBLASTS, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED LEW; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION, LEFT;

EID: 2442554080     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.12.045     Document Type: Article

References (24)

1. Freedman S.B., Isner J.M. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med. 136:2002;54-71
2. Udelson J.E., Dilsizian V., Laham R.J., et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation. 102:2000;1605-1610
3. Simons M., Annex B.H., Laham R.J., et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2 Double-blind, randomized, controlled clinical trial. Circulation. 105:2002;788-793
4. Grines C.L., Watkins M.W., Helmer G., et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 105:2002;1291-1297
5. Laham R.J., Sellke F.W., Edelman E.R., et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery Results of a phase i randomized, double-blind, placebo-controlled trial. Circulation. 100:1999;1865-1871
6. Vale P.R., Losordo D.W., Milliken C.E., et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation. 103:2001;2138-2143
7. Rosengart T.K., Lee L.Y., Patel S.R., et al. Angiogenesis gene therapy Phase i assessment of direct intramyocardial administration of an adenovirus vector expressing vegf121 cdna to individuals with clinically significant severe coronary artery disease. Circulation. 100:1999;468-474
8. Hariawala M.D., Horowitz J.R., Esakof D., et al. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res. 63:1996;77-82
9. Lopez J.J., Laham R.J., Carrozza J.P., et al. Hemodynamic effects of intracoronary VEGF delivery Evidence of tachyphylaxis and no dependence of response. Am J Physiol. 273:1997;H1317-H1323
10. Askari A., Unzek S., Popovic Z.B., et al. Effect of stromal-cell-derived factor-1 on stem cell homing and tissue regeneration in ischemic cardiomyopathy. Lancet. 362:2003;697-703
11. Scorsin M., Hagege A., Vilquin J.T., et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 119:2000;1169-1175
12. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium Improved performance after skeletal myoblast transplantation. Nat Med. 4:1998;929-933
13. Koh G.Y., Klug M.G., Soonpaa M.H., Field L.J. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest. 92:1993;1548-1554
14. Penn M.S., Francis G.S., Ellis S.G., Young J.B., McCarthy P.M., Topol E.J. Autologous cell therapy for the treatment of damaged myocardium. Prog Cardiovasc Dis. 45:2002;21-32
15. Menasche P., Hagege A.A., Scorsin M., et al. Myoblast transplantation for heart failure. Lancet. 357:2001;279-280
16. Askari A., Brennan M.L., Zhou X., et al. Myeloperoxidase and plasminogen activator inhibitor-1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med. 197:2003;615-624
17. Chinnadurai G., Chinnadurai S., Brusca J. Physical mapping of a large-plaque mutation of adenovirus type 2. J Virol. 32:1979;623-628
18. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 7:2001;430-436
19. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., Blau H.M. VEGF gene delivery to myocardium Deleterious effects of unregulated expression. Circulation. 102:2000;898-901
20. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol. 41:2003;1078-1083
21. Koh G.Y., Kim S.J., Klug M.G., Park K., Soonpaa M.H., Field L.J. Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest. 95:1995;114-121
22. Suzuki K., Murtuza B., Smolenski R.T., et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation. 104:2001;I207-I212
23. Yau T.M., Fung K., Weisel R.D., Fujii T., Mickle D.A., Li R.K. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation. 104:2001;I218-I222
24. Wright M.J., Wightman L.M., Lilley C., et al. In vivo myocardial gene transfer Optimization, evaluation and direct comparison of gene transfer vectors. Basic Res Cardiol. 96:2001;227-236